All Type of News
3 organizations related to chronic disease delivered policy suggestions before election
The Korean Diabetes Association(KDA), Korean Society for the Study of Obesity(KOSSO) and Korea Insulin Dependent Diabetes Association(IDDM) visited the National Assembly Health & Welfare Committee in the afternoon of ...
MOHW will classify ‘emergency household product list’ by therapeutic category
It has started to adjust the list of emergency household products.
The Ministry of Health and Welfare(MOHW) announced it will hold the 2nd meeting for the council for adjustment of the emergency household product lis...
Debate to revive excellent Korean drugs, such as generics
The pharmaceutical distribution industry’s ‘Korean Drug Revival Movement’ has met a new phase.
The Minjoo Party Rep. Sae-Jae Oh held the ‘Korean Drug Revival Debate for Development of Pharmaceutical Industry’ at the ...
Sanofi appoints CEOs for Consumer Healthcare and Diabetes & Circulatory Divisions
On the 28th, Sanofi-Aventis Korea(CEO Kyung-Eun Bae), a pharmaceutical business division of the global healthcare company Sanofi, announced appointment of the former Boehringer Ingelheim Korea Consumer Healthcare Divi...
KPBMA completes personnel appointment
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association(Chairman Hee-Mok Won, KPBMA) held the 6th Chairmen’s Meeting on the 28th and decided the agenda of chairmen appointment for the association’s committee...
Listed pharmas’ operating profit ratio dropped in KOSPI, but increased in KOSDAQ
Last year, the KOSPI listed pharmaceutical companies’ average operating profit ratio was significantly decreased, but the one of KOSDAQ listed pharmaceutical companies was increased by more than 10%.
According to the...
BAI’s inspection result on MOHW this April
Whien it comes to Hanmi Pharm’s concealment of side effect and delayed notice about the ‘Olita Tab’ clinical trial, the Board of Audit and Inspection of Korea(BAI) will reveal the inspection result on the Ministry of ...
Santen Pharmaceutical Korea appoints VP Han-Woong Lee as new CEO
Santen Pharmaceutical Korea announced on the 27th that it promoted Vice President Han-Woong Lee, Head-Pharmaceutical Business, to President and appointed him as a new CEO from the 1st of April.
Vice President Han-Woo...
KPA signs policy agreement with the Minjoo Party’s health & medical committee
The pharmaceutical association signed a policy agreement with the Minjoo Party’s Special Committee for Health and Medical Services.
The Korean Pharmaceutical Association(Chairman Chan-Hwi Cho, KPA) announced it has s...
Kuhnil & Daiichi Sankyo’s joint sales of dyslipidemia treatment ‘Mevalotin’
For ‘Mevalotin(generic name: pravastatin),’ the dyslipidemia treatment, Kuhnil Pharm(CEO Young-Joong Kim) and Daiichi Sankyo Korea(CEO Dae-Joong Kim) will started the joint sales from the 1st of April.
Daiichi Sankyo...
